F. Maas

660 total citations
26 papers, 480 citations indexed

About

F. Maas is a scholar working on Rheumatology, Immunology and Orthopedics and Sports Medicine. According to data from OpenAlex, F. Maas has authored 26 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Rheumatology, 15 papers in Immunology and 5 papers in Orthopedics and Sports Medicine. Recurrent topics in F. Maas's work include Spondyloarthritis Studies and Treatments (23 papers), Psoriasis: Treatment and Pathogenesis (14 papers) and Rheumatoid Arthritis Research and Therapies (13 papers). F. Maas is often cited by papers focused on Spondyloarthritis Studies and Treatments (23 papers), Psoriasis: Treatment and Pathogenesis (14 papers) and Rheumatoid Arthritis Research and Therapies (13 papers). F. Maas collaborates with scholars based in Netherlands, Germany and United States. F. Maas's co-authors include Suzanne Arends, Hendrika Bootsma, Elisabeth Brouwer, Anneke Spoorenberg, F. Wink, E. van der Veer, Reinhard Bos, M. Efdé, Nic J.G.M. Veeger and Peter M. A. van Ooijen and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

F. Maas

25 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Maas Netherlands 13 428 190 125 94 38 26 480
J. Sieper Germany 8 520 1.2× 287 1.5× 69 0.6× 132 1.4× 33 0.9× 15 585
R. Bonin United States 8 345 0.8× 221 1.2× 160 1.3× 89 0.9× 55 1.4× 13 472
Martin Hedberg Sweden 8 432 1.0× 189 1.0× 191 1.5× 91 1.0× 66 1.7× 8 527
Bassel Elzorkany Egypt 8 327 0.8× 164 0.9× 40 0.3× 127 1.4× 13 0.3× 25 390
Guo Xia China 10 254 0.6× 241 1.3× 21 0.2× 101 1.1× 31 0.8× 12 375
C. Downham United Kingdom 3 437 1.0× 177 0.9× 55 0.4× 110 1.2× 46 1.2× 5 523
Natalia Palmou‐Fontana Spain 13 280 0.7× 131 0.7× 34 0.3× 127 1.4× 25 0.7× 27 508
Linda Carli Italy 11 195 0.5× 95 0.5× 18 0.1× 31 0.3× 47 1.2× 19 288
Celia Erausquin Spain 10 176 0.4× 117 0.6× 39 0.3× 26 0.3× 69 1.8× 21 289
Miriam Teoli Italy 11 157 0.4× 244 1.3× 12 0.1× 91 1.0× 24 0.6× 22 384

Countries citing papers authored by F. Maas

Since Specialization
Citations

This map shows the geographic impact of F. Maas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Maas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Maas more than expected).

Fields of papers citing papers by F. Maas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Maas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Maas. The network helps show where F. Maas may publish in the future.

Co-authorship network of co-authors of F. Maas

This figure shows the co-authorship network connecting the top 25 collaborators of F. Maas. A scholar is included among the top collaborators of F. Maas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Maas. F. Maas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wink, F., F. Maas, Reinhard Bos, et al.. (2024). Improvement of bone mineral density and new vertebral fractures during 8 years of TNF-α inhibition in patients with axial spondyloarthritis. Seminars in Arthritis and Rheumatism. 68. 152523–152523. 1 indexed citations
2.
3.
Rademacher, Judith, F. Wink, F. Maas, et al.. (2022). Baseline serum biomarkers of inflammation, bone turnover and adipokines predict spinal radiographic progression in ankylosing spondylitis patients on TNF inhibitor therapy. Seminars in Arthritis and Rheumatism. 53. 151974–151974. 13 indexed citations
4.
Paap, Davy, F. Maas, Hendrika Bootsma, et al.. (2021). The mSQUASH; a valid, reliable and responsive questionnaire for daily physical activity in patients with axial spondyloarthritis. Seminars in Arthritis and Rheumatism. 51(4). 719–727. 12 indexed citations
5.
Arends, Suzanne, F. Wink, Reinhard Bos, et al.. (2020). Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis. British Journal of Clinical Pharmacology. 87(2). 644–651. 3 indexed citations
6.
Spoorenberg, Anneke, F. Maas, Elisabeth Brouwer, et al.. (2018). Ankylosing spondylitis disease activity score is related to NSAID use, especially in patients treated with TNF-α inhibitors. PLoS ONE. 13(4). e0196281–e0196281. 14 indexed citations
7.
8.
Wink, F., Suzanne Arends, F. Maas, et al.. (2018). High prevalence of hip involvement and decrease in inflammatory ultrasound lesions during tumour necrosis factor-α blocking therapy in ankylosing spondylitis. Lara D. Veeken. 58(6). 1040–1046. 10 indexed citations
9.
Maas, F., Suzanne Arends, F. Wink, et al.. (2017). Ankylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-α inhibitors. PLoS ONE. 12(6). e0177231–e0177231. 30 indexed citations
10.
Arends, Suzanne, Caroline Roozendaal, P. C. Limburg, et al.. (2017). Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands. Annals of the Rheumatic Diseases. 76(7). 1184–1190. 73 indexed citations
11.
12.
Bruyn, George A. W., F. Maas, E. N. Griep, et al.. (2017). Ultrasound Evaluation of the Entheses in Daily Clinical Practice during Tumor Necrosis Factor-α Blocking Therapy in Patients with Ankylosing Spondylitis. The Journal of Rheumatology. 44(5). 587–593. 11 indexed citations
13.
Schaper, Fred, Karina de Leeuw, Gerda Horst, et al.. (2017). Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus. Clinical & Experimental Immunology. 188(3). 412–419. 15 indexed citations
14.
Maas, F., Anneke Spoorenberg, Elisabeth Brouwer, et al.. (2016). Radiographic damage and progression of the cervical spine in ankylosing spondylitis patients treated with TNF-α inhibitors: Facet joints vs. vertebral bodies. Seminars in Arthritis and Rheumatism. 46(5). 562–568. 23 indexed citations
15.
Maas, F., Anneke Spoorenberg, E. van der Veer, et al.. (2016). Clinical Risk Factors for the Presence and Development of Vertebral Fractures in Patients With Ankylosing Spondylitis. Arthritis Care & Research. 69(5). 694–702. 40 indexed citations
16.
Maas, F., Suzanne Arends, Elisabeth Brouwer, et al.. (2016). SAT0379 Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment with Tnf Inhibitors: Results from The Glas Cohort. Annals of the Rheumatic Diseases. 75. 805–805. 2 indexed citations
17.
Maas, F., Suzanne Arends, Elisabeth Brouwer, et al.. (2016). Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors. Arthritis Care & Research. 69(7). 1011–1019. 71 indexed citations
18.
Maas, F., Suzanne Arends, E. van der Veer, et al.. (2015). Obesity Is Common in Axial Spondyloarthritis and Is Associated with Poor Clinical Outcome. The Journal of Rheumatology. 43(2). 383–387. 66 indexed citations
19.
Maas, F., Anneke Spoorenberg, Elisabeth Brouwer, et al.. (2015). Spinal Radiographic Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Blocking Therapy: A Prospective Longitudinal Observational Cohort Study. PLoS ONE. 10(4). e0122693–e0122693. 45 indexed citations
20.
Arends, Suzanne, Elisabeth Brouwer, F. Wink, et al.. (2015). THU0239 Drug Survival and Clinical Efficacy of 7 Years Etanercept Treatment in Patients with Ankylosing Spondylitis: Results from the Glas Cohort. Annals of the Rheumatic Diseases. 74. 283–283. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Sieper Breakdown of academic impact, for papers by R. Bonin Breakdown of academic impact, for papers by Martin Hedberg Breakdown of academic impact, for papers by Bassel Elzorkany Breakdown of academic impact, for papers by Guo Xia Breakdown of academic impact, for papers by C. Downham Breakdown of academic impact, for papers by Natalia Palmou‐Fontana Breakdown of academic impact, for papers by Linda Carli Breakdown of academic impact, for papers by Celia Erausquin Breakdown of academic impact, for papers by Miriam Teoli
Rankless by CCL
2026